Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
3 hedge funds and large institutions have $90K invested in Bio Green Med Solution Inc Preferred Stock in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.28% less ownership
Funds ownership: 4.49% → 4.2% (-0.28%)
4% less capital invested
Capital invested by funds: $94K → $90K (-$4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$8.92K |
BGMSP Hedge Fund Activity: Q1 2017 in Review
3 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q1 2017, worth a combined $90K — down 4.3% from $94K a quarter earlier.
Fund positioning in BGMSP was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $2.56K. The largest seller was UBS Group, cutting an estimated $8.92K.
- 3 institutional investors held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $90K of Bio Green Med Solution Inc Preferred Stock stock for Q1 2017, down 4.3% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q1 2017 and 0 closed out.
- The largest Bio Green Med Solution Inc Preferred Stock buyer in Q1 2017 was Tower Research Capital (TRC), an estimated $2.56K added.
- The largest Bio Green Med Solution Inc Preferred Stock seller in Q1 2017 was UBS Group, an estimated $8.92K sold.
Based on aggregated 13F filings for Q1 2017.